Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Accumulated Expenses (2017 - 2021)

Historic Accumulated Expenses for Cogent Biosciences (COGT) over the last 5 years, with Q3 2021 value amounting to $7.0 million.

  • Cogent Biosciences' Accumulated Expenses rose 2731.71% to $7.0 million in Q3 2021 from the same period last year, while for Sep 2021 it was $7.0 million, marking a year-over-year increase of 2731.71%. This contributed to the annual value of $4.8 million for FY2020, which is 3298.28% down from last year.
  • Cogent Biosciences' Accumulated Expenses amounted to $7.0 million in Q3 2021, which was up 2731.71% from $6.4 million recorded in Q2 2021.
  • Cogent Biosciences' Accumulated Expenses' 5-year high stood at $7.1 million during Q4 2019, with a 5-year trough of $357000.0 in Q1 2018.
  • Moreover, its 5-year median value for Accumulated Expenses was $5.6 million (2020), whereas its average is $4.7 million.
  • In the last 5 years, Cogent Biosciences' Accumulated Expenses soared by 159943.98% in 2019 and then plummeted by 5508.74% in 2021.
  • Quarter analysis of 5 years shows Cogent Biosciences' Accumulated Expenses stood at $3.0 million in 2017, then surged by 85.47% to $5.5 million in 2018, then soared by 30.2% to $7.1 million in 2019, then crashed by 32.98% to $4.8 million in 2020, then skyrocketed by 47.46% to $7.0 million in 2021.
  • Its Accumulated Expenses stands at $7.0 million for Q3 2021, versus $6.4 million for Q2 2021 and $2.8 million for Q1 2021.